Annual report pursuant to Section 13 and 15(d)

Cover
- Document and Entity Information
Financial Statements
Notes to Financial Statements
Accounting Policies
- Significant Accounting Policies (Policies)
Notes Tables
Notes Details

License Agreements (Details)

v3.6.0.2

License Agreements (Details) - USD ($)		1 Months Ended	12 Months Ended
License Agreements (Details) - USD ($)	Sep. 22, 2016	Feb. 28, 2015	Dec. 31, 2016	Dec. 31, 2013
License Agreement To Develop Transmembrane Ampa Receptor Regulatory Proteins
Asset Acquisition And License Agreement [Line Items]
Asset acquisition payments	$ 2,000,000		$ 750,000
Potential Milestone Commitment Due After First Subject Closed			1,250,000
License Agreement To Develop Transmembrane Ampa Receptor Regulatory Proteins \| Research and development expense
Asset Acquisition And License Agreement [Line Items]
Asset acquisition payments			2,000,000
Merck \| CERC-301
Asset Acquisition And License Agreement [Line Items]
Other Commitment				$ 750,000
Total Cost of License Agreement				1,500,000
Merck \| CERC-301 \| Research and development expense
Asset Acquisition And License Agreement [Line Items]
Asset acquisition payments				750,000
Merck \| COMT Inhibitor
Asset Acquisition And License Agreement [Line Items]
Asset acquisition payments				$ 200,000
Lilly \| CERC-501
Asset Acquisition And License Agreement [Line Items]
Other Commitment			$ 250,000
Lilly \| CERC-501 \| Research and development expense
Asset Acquisition And License Agreement [Line Items]
Asset acquisition payments		$ 750,000

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	cerc_AssetAcquisitionAndLicenseAgreementLineItems
Namespace Prefix:	cerc_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Potential Milestone Commitment Due After First Subject Closed

+ References

No definition available.

+ Details

Name:	cerc_PotentialMilestoneCommitmentDueAfterFirstSubjectClosed
Namespace Prefix:	cerc_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

The total amount that the entity may be liable to pay for the license agreement, including amounts paid at inception and amounts contingent on achievement of milestones.

+ References

No definition available.

+ Details

Name:	cerc_TotalCostOfLicenseAgreement
Namespace Prefix:	cerc_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Minimum amount of other commitment not otherwise specified in the taxonomy. Excludes commitments explicitly modeled in the taxonomy, including but not limited to, long-term and short-term purchase commitments, recorded and unrecorded purchase obligations, supply commitments, registration payment arrangements, leases, debt, product warranties, guarantees, environmental remediation obligations, and pensions.

+ References

No definition available.

+ Details

Name:	us-gaap_OtherCommitment
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 13
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3213-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Investing Activities
-URI http://asc.fasb.org/extlink&oid=6516133

+ Details

Name:	us-gaap_PaymentsToAcquireIntangibleAssets
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Details

Name:	us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=cerc_LicenseAgreementToDevelopTransmembraneAmpaReceptorRegulatoryProteinsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_CounterpartyNameAxis=cerc_MerckAsCounterpartyMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=cerc_LicenseAgreementToDevelopCertainSmallMoleculeCompoundsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=cerc_LicenseAgreementToDevelopComtInhibitorCompoundMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_CounterpartyNameAxis=cerc_ElilillyAndCompanyMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=us-gaap_LicenseAgreementTermsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: